Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
2016
844 citations
Journal Article
Field-Weighted Citation Impact:
86.54
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial | Researchclopedia
Amrita Krishnan
·
City of Hope
Robert Vescio
·
Cedars-Sinai Medical Center
María‐Victoria Mateos
·
Instituto de Investigación Biomédica de Salamanca
Amitabha Mazumder
·
NYU Langone Health
Robert Z. Orlowski
·
The University of Texas MD Anderson Cancer Center
Heather J. Sutherland
·
University of British Columbia
Joan Bladé
·
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Emma C. Scott
·
Oregon Health & Science University
Albert Oriol
·
Institut Català d'Oncologia
Jesús G. Berdeja
·
Sarah Cannon
Mecide Gharibo
·
Rutgers Cancer Institute
Don A. Stevens
·
Norton Healthcare
Richard LeBlanc
·
Hôpital Maisonneuve-Rosemont
Michaël Sébag
·
Royal Victoria Hospital
Natalie S. Callander
·
University of Wisconsin–Madison
Andrzej Jakubowiak
·
University of Chicago
Darrell White
·
Dalhousie University
Javier de la Rubia
·
Valencia Catholic University Saint Vincent Martyr
Paul G. Richardson
·
Dana-Farber Cancer Institute
Steen Lisby
·
Genmab (Denmark)
Huaibao Feng
·
Janssen (United States)
Clarissa Uhlar
·
Janssen (United States)
Imran Khan
·
Janssen (United States)
Tahamtan Ahmadi
·
Janssen (United States)
Peter M. Voorhees
·
University of North Carolina at Chapel Hill